期刊文献+

血浆外泌体microRNA-29c在阿尔茨海默病早期诊断价值的初步研究 被引量:11

The preliminary study on the diagnostic value of plasma exosomes microRNA-29c in the early diagnosis of the Alzheimer's disease
下载PDF
导出
摘要 目的初步探讨血浆外泌体内microRNA-29c(miR-29c)在阿尔茨海默病(AD)早期诊断种的价值。方法明确血浆外泌体内miR-29c提取和检测过程的稳定性;检测202例轻度认知障碍(MCI)和痴呆期(DAT)AD患者及120例表面健康受试者的血浆外泌体内miR-29c,建立其生物参考区间,确定截断值,比较其诊断效能。结果对照组、帕金森患者、血管性痴呆患者、MCI和DAT患者miR-29c的回收率均在95%-105%之间,且各组受试者间的回收率无统计学差异(P>0.05);MCI和DAT患者血浆外泌体内miR-29c均显著低于对照组、帕金森患者和血管性痴呆患者(P<0.05),且DAT患者显著低于MCI患者(P<0.05);对照组、帕金森患者和血管性痴呆患者血浆外泌体内miR-29c水平无显著性差异(P>0.05);使用截断值诊断MCI和DAT的灵敏度高于生物参考区间法(P>0.05)。结论外泌体内miR-29c可作为AD诊断,特别是早期诊断的候选生物标志物,且应使用其截断值而不是生物参考区间对AD进行早期诊断。 Objective To investigate the value of microRNA-29 c(miR-29 c)in the early diagnosis of Alzheimer's disease(AD)in plasma exosomes.Methods The stability of the extraction and detection of miR-29 cin plasma exosomes was clarified.The expression of miR-29 cin plasma exosomes in 202 patients with mild cognitive impairment(MCI)and dementia(DAT)and 120 healthy controls-29 c,establish its biological reference interval,determine the cut-off value,compare its diagnostic efficacy.Results The recovery of miR-29 cin control group,Parkinson's disease,vascular dementia,MCI and DAT patients were between 95% and 105%,and there was no significant difference between the two groups(P〉0.05).The levels of miR-29 cin plasma exosomes in MCI and DAT patients were significantly lower than those in control group,Parkinson's disease patients and vascular dementia patients(P〈0.05),and those in DAT patients were significantly lower than those in MCI patients(P〈0.05).There was no significant difference in the level of miR-29 cin the plasma exosomes between patients with Parkinson's disease and those with vascular dementia(P〉0.05).The sensitivity of using the cutoffs to diagnose MCI and DAT was higher than that of the biological reference interval method(P〉0.05).Conclusion MiR-29 cin exosomes can be used as a candidate biomarker for the diagnosis of AD,especially for early diagnosis,and early diagnosis of AD should be performed using its cutoff instead of the biological reference interval.
作者 刘辰庚 郝婷 杨婷婷 孟双 王培昌 LIU Chen-geng;HAO Ting;YANG Ting-ting(Xuanwu Hospital ,Captital Medcial University, Beijing 100053, China;Department of Pathology, Heze Municipal Hospital;State Key Laboratory for Infec- tious Disease Prevention and Control,National Institute for Communicable Disease Control and Prevention)
出处 《中国实验诊断学》 2018年第5期761-764,共4页 Chinese Journal of Laboratory Diagnosis
基金 国家自然科学基金青年基金(项目编号:81401734) 北京市医院管理局"青苗"计划专项经费资助(编号:QML20150804)
关键词 阿尔茨海默病 MICRORNA 外泌体 生物标志物 Alzheimer' s disease microRNA exosome biomarker
  • 相关文献

参考文献2

二级参考文献46

  • 1Jack C, Albert M, Knopman D, et al. Introduction to the revised criteria for Alzheimer' s disease: National Institute on AgingAtzheimer' s Association Workgroups. Alzheimers Dement, 2011, in press.
  • 2McKhann G, Knopman D, Chertkow H, et al. The National Institute on Aging-Alzheimer' s Association Workgroup on the diagnosis of dementia due to Alzheimer' s disease. Alzheimers Dement, 2011, in press.
  • 3Sperling R, Aisen P, Beckett L, et al. Towards defining the preclinical stages of Alzheimer' s disease: National Institute on Aging and Alzheimer' s Association Workgroup. Alzheimers Dement, 2011, in press.
  • 4Lyketsos C, Colenda C, Beck C, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer' s disease. Am J Geriatr Psychiatry, 2006, 14: 561-572.
  • 5Petersen RC, Smith G, Waring S, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol, 1999, 56 : 303-308.
  • 6Petersen RC. Mild cognitive impairment. J Int Med, 2004, 256: 183-194.
  • 7Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer' s disease: revising the NINCDS- ADRDA criteria. Lancet Neurol, 2007, 6 : 734-746.
  • 8Bennett D, Schneider J, Bienias J, et al. Mild cognitive impairment is related to Alzheimer pathology and cerebral infarctions. Neurology, 2005, 64: 834-41.
  • 9Markesbery WR, Schmitt RA, Kryscio R J, et al. Neuropathologic substrate of mild cognitive impairment. Arch Neurol, 2006, 63 : 38-46.
  • 10Petersen RC, Parisi JE, Dickson DW, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol, 2006, 63 : 665-672.

共引文献90

同被引文献76

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部